DAPA-HF: does dapagliflozin provide 'bang for your buck' as a treatment forheart failure with reduced ejection fraction?

被引：1

作者：

Cowie, Martin R. ^{[1
]}

机构：

[1] Imperial Coll London, Dept Cardiol, Royal Brompton Hosp, London, England

来源：

EUROPEAN JOURNAL OF HEART FAILURE | 2020年 / 22卷 / 11期

关键词：

COST-EFFECTIVENESS; HEART-FAILURE;

D O I：

10.1002/ejhf.1982

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

页码：2157 / 2159

页数：3

共 13 条

[1]

Amod A, 2020, DIABETES THER, V11, P53, DOI [10.1007/s13300-019-00715-x, 10.2337/dci19-0066]

[2]

Cosentino F, 2020, CIRCULATION

[3] 2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD [J].

Cosentino, Francesco ;

Grant, Peter J. ;

Aboyans, Victor ;

Bailey, Clifford J. ;

Ceriello, Antonio ;

Delgado, Victoria ;

Federici, Massimo ;

Filippatos, Gerasimos ;

Grobbee, Diederick E. ;

Hansen, Tina Birgitte ;

Huikuri, Heikki, V ;

Johansson, Isabelle ;

Juni, Peter ;

Lettino, Maddalena ;

Marx, Nikolaus ;

Mellbin, Linda G. ;

Ostgren, Carl J. ;

Rocca, Bianca ;

Roffi, Marco ;

Sattar, Naveed ;

Seferovic, Petar M. ;

Sousa-Uva, Miguel ;

Valensi, Paul ;

Wheeler, David C. ;

Piepoli, Massimo Francesco ;

Birkeland, Kare, I ;

Adamopoulos, Stamatis ;

Ajjan, Ramzi ;

Avogaro, Angelo ;

Baigent, Colin ;

Brodmann, Marianne ;

Bueno, Hector ;

Ceconi, Claudio ;

Chioncel, Ovidiu ;

Coats, Andrew ;

Collet, Jean-Philippe ;

Collins, Peter ;

Cosyns, Bernard ;

Di Mario, Carlo ;

Fisher, Miles ;

Fitzsimons, Donna ;

Halvorsen, Sigrun ;

Hansen, Dominique ;

Hoes, Arno ;

Holt, Richard I. G. ;

Home, Philip ;

Katus, Hugo A. ;

Khunti, Kamlesh ;

Komajda, Michel ;

Lambrinou, Ekaterini .

EUROPEAN HEART JOURNAL, 2020, 41 (02) :255-323

[4] SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control [J].

Cowie, Martin R. ;

Fisher, Miles .

NATURE REVIEWS CARDIOLOGY, 2020, 17 (12) :761-772

[5] The cost effectiveness of ivabradine in the treatment of chronic heart failure from the UK National Health Service perspective [J].

Griffiths, A. ;

Paracha, N. ;

Davies, A. ;

Branscombe, N. ;

Cowie, M. R. ;

Sculpher, M. .

HEART, 2014, 100 (13) :1031-1036

[6] Cost-effectiveness of dapagliflozin as a treatment for heart failure with reduced ejection fraction: a multinational health-economic analysis ofDAPA-HF [J].

McEwan, Phil ;

Darlington, Oliver ;

McMurray, John J. V. ;

Jhund, Pardeep S. ;

Docherty, Kieran F. ;

Boehm, Michael ;

Petrie, Mark C. ;

Bergenheim, Klas ;

Qin, Lei .

EUROPEAN JOURNAL OF HEART FAILURE, 2020, 22 (11) :2147-2156

[7] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction [J].

McMurray, J. J. V. ;

Solomon, S. D. ;

Inzucchi, S. E. ;

Kober, L. ;

Kosiborod, M. N. ;

Martinez, F. A. ;

Ponikowski, P. ;

Sabatine, M. S. ;

Anand, I. S. ;

Belohlavek, J. ;

Bohm, M. ;

Chiang, C. -E. ;

Chopra, V. K. ;

de Boer, R. A. ;

Desai, A. S. ;

Diez, M. ;

Drozdz, J. ;

Dukat, A. ;

Ge, J. ;

Howlett, J. G. ;

Katova, T. ;

Kitakaze, M. ;

Ljungman, C. E. A. ;

Merkely, B. ;

Nicolau, J. C. ;

O'Meara, E. ;

Petrie, M. C. ;

Vinh, P. N. ;

Schou, M. ;

Tereshchenko, S. ;

Verma, S. ;

Held, C. ;

DeMets, D. L. ;

Docherty, K. F. ;

Jhund, P. S. ;

Bengtsson, O. ;

Sjostrand, M. ;

Langkilde, A. -M. .

NEW ENGLAND JOURNAL OF MEDICINE, 2019, 381 (21) :1995-2008

[8] Cost-effectiveness of sacubitril/valsartan in the treatment of heart failure with reduced ejection fraction [J].

McMurray, John J. V. ;

Trueman, David ;

Hancock, Elizabeth ;

Cowie, Martin R. ;

Briggs, Andrew ;

Taylor, Matthew ;

Mumby-Croft, Juliet ;

Woodcock, Fionn ;

Lacey, Michael ;

Haroun, Rola ;

Deschaseaux, Celine .

HEART, 2018, 104 (12) :1006-1013

[9] Angiotensin-Neprilysin Inhibition versus Enalapril in Heart Failure [J].

McMurray, John J. V. ;

Packer, Milton ;

Desai, Akshay S. ;

Gong, Jianjian ;

Lefkowitz, Martin P. ;

Rizkala, Adel R. ;

Rouleau, Jean L. ;

Shi, Victor C. ;

Solomon, Scott D. ;

Swedberg, Karl ;

Zile, Michael R. .

NEW ENGLAND JOURNAL OF MEDICINE, 2014, 371 (11) :993-1004

[10]

National Institute for Health and Care Excellence, SAC VALS TREAT SYMPT

← 1 2 →